115 related articles for article (PubMed ID: 2535715)
1. Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts.
He XM; Skapek SX; Wikstrand CJ; Friedman HS; Trojanowski JQ; Kemshead JT; Coakham HB; Bigner SH; Bigner DD
J Neuropathol Exp Neurol; 1989 Jan; 48(1):48-68. PubMed ID: 2535715
[TBL] [Abstract][Full Text] [Related]
2. Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts.
He XM; Wikstrand CJ; Friedman HS; Bigner SH; Pleasure S; Trojanowski JQ; Bigner DD
Lab Invest; 1991 Jun; 64(6):833-43. PubMed ID: 1904513
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc.
Friedman HS; Burger PC; Bigner SH; Trojanowski JQ; Brodeur GM; He XM; Wikstrand CJ; Kurtzberg J; Berens ME; Halperin EC
Am J Pathol; 1988 Mar; 130(3):472-84. PubMed ID: 3279793
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetate.
Stockhammer G; Manley GT; Johnson R; Rosenblum MK; Samid D; Lieberman FS
J Neurosurg; 1995 Oct; 83(4):672-81. PubMed ID: 7674018
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med.
Friedman HS; Burger PC; Bigner SH; Trojanowski JQ; Wikstrand CJ; Halperin EC; Bigner DD
J Neuropathol Exp Neurol; 1985 Nov; 44(6):592-605. PubMed ID: 4056828
[TBL] [Abstract][Full Text] [Related]
6. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
[TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma cell-substrate interaction in vitro.
Wikstrand CJ; Friedman HS; Bigner DD
Invasion Metastasis; 1991; 11(6):310-24. PubMed ID: 1822845
[TBL] [Abstract][Full Text] [Related]
8. Busulfan therapy of central nervous system xenografts in athymic mice.
Aaron RH; Elion GB; Colvin OM; Graham M; Keir S; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 1994; 35(2):127-31. PubMed ID: 7987988
[TBL] [Abstract][Full Text] [Related]
9. Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies.
Wikstrand CJ; Grahmann FC; McComb RD; Bigner DD
J Neuropathol Exp Neurol; 1985 May; 44(3):229-41. PubMed ID: 2580959
[TBL] [Abstract][Full Text] [Related]
10. Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents.
Friedman HS; Colvin OM; Skapek SX; Ludeman SM; Elion GB; Schold SC; Jacobsen PF; Muhlbaier LH; Bigner DD
Cancer Res; 1988 Aug; 48(15):4189-95. PubMed ID: 3390813
[TBL] [Abstract][Full Text] [Related]
11. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.
Shu Q; Antalffy B; Su JM; Adesina A; Ou CN; Pietsch T; Blaney SM; Lau CC; Li XN
Clin Cancer Res; 2006 Aug; 12(15):4687-94. PubMed ID: 16899619
[TBL] [Abstract][Full Text] [Related]
12. Detection of amino-terminal extracellular domain of somatostatin receptor 2 by specific monoclonal antibodies and quantification of receptor density in medulloblastoma.
Kuan CT; Wikstrand CJ; McLendon RE; Zalutsky MR; Kumar U; Bigner DD
Hybridoma (Larchmt); 2009 Dec; 28(6):389-403. PubMed ID: 20025498
[TBL] [Abstract][Full Text] [Related]
13. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
[TBL] [Abstract][Full Text] [Related]
14. Immunological low-dose radiation modulates the pediatric medulloblastoma antigens and enhances antibody-dependent cellular cytotoxicity.
Das A; McDonald D; Lowe S; Bredlau AL; Vanek K; Patel SJ; Cheshier S; Eskandari R
Childs Nerv Syst; 2017 Mar; 33(3):429-436. PubMed ID: 27942918
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody T-199 directed against human medulloblastoma: characterization of a new antigenic system expressed on neuroectodermal tumors and natural killer cells.
Feickert HJ; Pietsch T; Hadam MR; Mildenberger H; Riehm H
Cancer Res; 1989 Aug; 49(15):4338-43. PubMed ID: 2743322
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of a human cytotoxic T-cell line (TALL-104) in brain tumor xenografts.
Geoerger B; Tang CB; Cesano A; Visonneau S; Marwaha S; Judy KD; Sutton LN; Santoli D; Phillips PC
Neuro Oncol; 2000 Apr; 2(2):103-13. PubMed ID: 11303619
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
[TBL] [Abstract][Full Text] [Related]
18. Phosphate-dependent and independent neurofilament protein epitopes are expressed throughout the cell cycle in human medulloblastoma (D283 MED) cells.
Trojanowski JQ; Kelsten ML; Lee VM
Am J Pathol; 1989 Oct; 135(4):747-58. PubMed ID: 2478022
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of human medulloblastoma xenograft line.
Mikami T; Kurisu K; Kawamoto K; Kiya K; Mukada K; Hotta T; Ogasawara H; Sugiyama K; Uozumi T
Hiroshima J Med Sci; 1991 Mar; 40(1):41-5. PubMed ID: 1864766
[TBL] [Abstract][Full Text] [Related]
20. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
